M Maurer1, M Metz1, C Bindslev-Jensen2, J Bousquet3,4,5, G W Canonica6, M K Church1, K V Godse7, C E Grattan8, M Hide9, E Kocatürk10, M Magerl1, M Makris11, R Meshkova12, S S Saini13, G Sussman14, E Toubi15, Z Zhao16, T Zuberbier1, A Gimenez-Arnau17. 1. Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany. 2. Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis, Odense University Hospital, Odense, Denmark. 3. University Hospital, Montpellier, France. 4. VIMA: Ageing and Chronic Diseases, Epidemiological and Public Health Approaches, INSERM, Paris, France. 5. UVSQ, UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, St-Quentin-en-Yvelines, France. 6. IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy. 7. Department of Dermatology, D.Y. Patil School of Medicine, Nerul, Navi Mumbai, India. 8. Norfolk and Norwich University Hospital, Norwich, UK. 9. Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. 10. Department of Dermatology, Okmeydani Training and Research Hospital, Istanbul, Turkey. 11. 2nd Department of Dermatology and Venereology, Attikon University Hospital, Athens, Greece. 12. Department of Clinical Immunology and Allergy, Smolensk State Medical University, Smolensk, Russia. 13. Department of Medicine, Johns Hopkins University, Baltimore, MD, USA. 14. Division Allergy and Immunology, University of Toronto, Toronto, ON, Canada. 15. Allergy and Clinical Immunology, Bnai-Zion Medical Center, The Technion, Haifa, Israel. 16. Department of Dermatology and Venereology, Peking University, First Hospital, Beijing, China. 17. Department of Dermatology, Hospital del Mar, IMIM, Universitat Autònoma, Barcelona, Spain.
Abstract
BACKGROUND: GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard-to-treat conditions such as urticaria. AIMS: Here, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA²LEN UCAREs. RESULTS: The main aims of GA²LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. To become a certified GA²LEN UCARE, urticaria centers have to apply and fulfill 32 requirements, defined by specific deliverables that are assessed during an audit visit. DISCUSSION AND CONCLUSION: The GA²LEN UCARE program will result in a strong network of urticaria specialists, promote urticaria research, and harmonize and improve urticaria management globally.
BACKGROUND: GA²LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard-to-treat conditions such as urticaria. AIMS: Here, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA²LEN UCAREs. RESULTS: The main aims of GA²LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. To become a certified GA²LEN UCARE, urticaria centers have to apply and fulfill 32 requirements, defined by specific deliverables that are assessed during an audit visit. DISCUSSION AND CONCLUSION: The GA²LEN UCARE program will result in a strong network of urticaria specialists, promote urticaria research, and harmonize and improve urticaria management globally.
Authors: Pavel Kolkhir; Ana M Giménez-Arnau; Kanokvalai Kulthanan; Jonny Peter; Martin Metz; Marcus Maurer Journal: Nat Rev Dis Primers Date: 2022-09-15 Impact factor: 65.038
Authors: Ana Carolina Miranda Carvalho Ferreira Fernandes de Souza; Sérgio D Dortas Junior; Guilherme Gomes Azizi; Alfeu Tavares França; Omar Lupi; Solange O R Valle Journal: An Bras Dermatol Date: 2022-06-12 Impact factor: 2.113
Authors: Ivan Cherrez-Ojeda; Emanuel Vanegas; Annia Cherrez; Miguel Felix; Karsten Weller; Markus Magerl; Rasmus Robin Maurer; Valeria L Mata; Alicja Kasperska-Zajac; Agnieszka Sikora; Daria Fomina; Elena Kovalkova; Kiran Godse; Nimmagadda Dheeraj Rao; Maryam Khoshkhui; Sahar Rastgoo; Roberta Fj Criado; Mohamed Abuzakouk; Deepa Grandon; Martijn B A Van Doorn; Solange Oliveira Rodrigues Valle; Eduardo Magalhães De Souza Lima; Simon Francis Thomsen; German D Ramón; Edgar E Matos Benavides; Andrea Bauer; Ana M Giménez-Arnau; Emek Kocatürk; Carole Guillet; Jose Ignacio Larco; Zuo-Tao Zhao; Michael Makris; Carla Ritchie; Paraskevi Xepapadaki; Luis Felipe Ensina; Sofia Cherrez; Marcus Maurer Journal: World Allergy Organ J Date: 2021-06-04 Impact factor: 4.084
Authors: Kanokvalai Kulthanan; Leena Chularojanamontri; Chuda Rujitharanawong; Puncharas Weerasubpong; Marcus Maurer; Karsten Weller Journal: Health Qual Life Outcomes Date: 2019-10-26 Impact factor: 3.186